Positive news on Oxford/AstraZeneca Covid-19 vaccine could come Thursday
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
SATURDAY, MAY 21, 2022
SATURDAY, MAY 21, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Positive news on Oxford/AstraZeneca Covid-19 vaccine could come Thursday

Coronavirus chronicle

Reuters
15 July, 2020, 08:45 pm
Last modified: 15 July, 2020, 11:29 pm

Related News

  • Main negotiators reach 'outcome' on Covid vaccine IP waiver, WTO says
  • Britain approves Valneva's easy-to-store Covid shot
  • 95% of target population fully vaccinated: Health Minister
  • Help all reach vaccination targets, Hasina urges COVAX summit
  • Bharat Biotech on WHO's Covaxin supply suspension: No impact on efficacy, safety

Positive news on Oxford/AstraZeneca Covid-19 vaccine could come Thursday

More than 100 vaccines are being developed and tested around the world to try to stop the Covid-19 pandemic, which has killed hundreds of thousands and ravaged the global economy

Reuters
15 July, 2020, 08:45 pm
Last modified: 15 July, 2020, 11:29 pm
The ultrastructural morphology exhibited by the 2019 Novel Coronavirus, which was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China, is seen in an illustration released by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, US January 29, 2020/Reuters
The ultrastructural morphology exhibited by the 2019 Novel Coronavirus, which was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China, is seen in an illustration released by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, US January 29, 2020/Reuters

Positive news on initial trials of the University of Oxford's potential Covid-19 vaccine that has been licensed to AstraZeneca could be announced as soon as Thursday, ITV's political editor Robert Peston said, citing a source.

The potential vaccine is already in large-scale Phase III human trials to assess whether it can protect against Covid-19, but its developers have yet to report Phase I results which would show whether it is safe and whether or not it induces an immune response.

The developers of the vaccine said this month they were encouraged by the immune response they had seen in trials so far and were expecting to publish Phase 1 data by the end of July.

The data are expected to be published by The Lancet medical journal.

More than 100 vaccines are being developed and tested around the world to try to stop the Covid-19 pandemic, which has killed hundreds of thousands and ravaged the global economy.

AstraZeneca's experimental vaccine is probably the world's leading candidate and most advanced in terms of development, the World Health Organization's chief scientist said in June.

The company has signed agreements with governments around the globe to supply the vaccine should it be cleared for use.

Shares in AstraZeneca traded 5 percent higher by 1415 GMT. There was no immediate comment from the company on the report.

A spokeswoman for Oxford University told Reuters the team was awaiting confirmation from a scientific journal of a publication date and time for the data, but gave no further details. "(We) are not able to confirm when it will be released," she said.

Peston said in a blog post: "I am hearing there will be positive news soon (perhaps tomorrow) on initial trials of the Oxford Covid-19 vaccine that is backed by AstraZeneca."

Researchers in the United States reported on Tuesday that Moderna Inc's experimental vaccine showed it was safe and provoked immune responses in all 45 healthy volunteers in an ongoing early-stage study.

Moderna started its Phase II trial in May and expects to start a Phase III trial on July 27.

Top News

covid-19 vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Photo: Collected
    Hiking gas, electricity prices now will be suicidal: FBCCI
  • A vendor wearing plastic overalls and surgical mask, waiting at his stall for buyers at Karwan Bazar. The ever-bustling marketplace has very few buyers now as many people have either left the city or are purchasing online to avoid going out. Photo: Mumit M/TBS
    Grocers’ plight as sales on credit increase
  • Policies on cards to pave way for private heliports, helipads
    Policies on cards to pave way for private heliports, helipads

MOST VIEWED

  • Photo: Collected
    Thousands of Covid-negative Beijing residents sent to quarantine
  • A man checks phone at Lujiazui financial district in Pudong, Shanghai, China March 14, 2019. Photo :Reuters
    Shanghai inches towards Covid lockdown exit, Beijing plays defence
  • North Korean leader Kim Jong Un delivers opening remarks during the 2nd Conference of Secretaries of Primary Committees of the Workers' Party of Korea (WPK), in this photo released on February 27, 2022 by North Korea's Korean Central News Agency (KCNA). KCNA via REUTERS/File Photo
    N Korea reports over 200,000 fever cases for 5th day amid Covid wave
  • A worker disinfects a vehicle carrying medical oxygen, in Pyongyang. Photo: Collected
    North Korea using traditional medicine to fight Covid
  • Ryu Yong Chol, an official at North Korea's state emergency epidemic prevention headquarters, speaks during a daily coronavirus program on state-run television KRT, in this still image obtained from KRT footage released on May 20, 2022. REUTERS TV/KRT via REUTERS
    North Korea's Dr Fauci? Health official emerges as face of Covid campaign
  • Workers in protective suit spray disinfectant at a community, during the lockdown to curb the spread of the coronavirus disease (COVID-19) in Shanghai, China, April 5, 2022. REUTERS/Aly Song
    Shanghai detects new infections after five days of 'zero Covid'

Related News

  • Main negotiators reach 'outcome' on Covid vaccine IP waiver, WTO says
  • Britain approves Valneva's easy-to-store Covid shot
  • 95% of target population fully vaccinated: Health Minister
  • Help all reach vaccination targets, Hasina urges COVAX summit
  • Bharat Biotech on WHO's Covaxin supply suspension: No impact on efficacy, safety

Features

The Buffalo shooter targeted Black people, linking mass migration with environmental degradation and other eco-fascist ideas. Photo: Reuters

Eco-fascism: The greenwashing of the far right

1h | Panorama
Green-backed Heron on a tilting stalk. Photo: Enam Ul Haque

Green-backed Heron: Nothing but a prayer to catch a fish  

3h | Panorama
Illustration: TBS

‘High logistics cost weakens Bangladesh’s competitiveness’

5h | Panorama
Every morning is a new beginning for all

Seashore

5h | In Focus

More Videos from TBS

Photo: TBS

US Congress to hold first public UFO panel

1h | Videos
Pollution killing 9 million people a year

Pollution killing 9 million people a year

1h | Videos
Photo: TBS

Steps necessary to ensure economic stability

1h | Videos
Photo: TBS

The right way to apply for jobs at int'l orgs

1h | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
A packet of US five-dollar bills is inspected at the Bureau of Engraving and Printing in Washington March 26, 2015. REUTERS/Gary Cameron
Banking

Dollar hits Tk100 mark in open market

3
The story of Bangladesh becoming a major bicycle exporter
Industry

The story of Bangladesh becoming a major bicycle exporter

4
PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire
Crime

PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire

5
Representative Photo: Pixabay.
Bangladesh

Microplastics found in 5 local sugar brands

6
Mushfiq Mobarak. Photo: Noor-A-Alam
Panorama

Meet the Yale professor who anchors his research in Bangladesh and scales up interventions globally

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab